Trade Summary

1 week ago, Tatsis Ourania, serving as EVP, Chief Reg. & Quality Off. at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 1,500 shares at $524.99 per share, for a total transaction value of $787,485.00. Following this transaction, Tatsis Ourania now holds 45,321 shares of VRTX.

This sale represents a 3.20% decrease in Tatsis Ourania's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, July 2, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, July 7, 2026 at 4:15 PM ET, 5 days after the trade was made.

VERTEX PHARMACEUTICALS INC / MA operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.